Lineage, Inc. logo LINE - Lineage, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 4
HOLD 9
SELL 3
STRONG
SELL 0
| PRICE TARGET: $45.36 DETAILS
HIGH: $53.00
LOW: $35.00
MEDIAN: $46.00
CONSENSUS: $45.36
UPSIDE: 11.83%

Stock News

KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering

KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering

BOCA RATON, Fla., Aug. 17, 2026 (GLOBE NEWSWIRE) -- KARMAN LINE ACQUISITION CORP. (the “Company”), a special purpose acquisition company, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to be listed for trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “XTERU” beginning August 18, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “XTER” and “XTERW,” respectively. The offering is expected to close on August 19, 2026, subject to customary closing conditions.

Aug 17, 2026 05:46 PM • globenewswire.com
Lineage, Inc. Reports Second-Quarter 2026 Financial Results

Lineage, Inc. Reports Second-Quarter 2026 Financial Results

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced its financial results for the second quarter of 2026. Second-Quarter 2026 Financial Highlights Total revenue increased 0.8% to $1,361 million GAAP net loss of $(32) million, or $(0.13) per diluted common share Adjusted EBITDA decreased (1.8)% to $320 million; adjusted EBITDA margin decreased (60)bps to 23.5% AFFO decreased (6.2)% to $198 m.

Aug 05, 2026 02:00 AM • businesswire.com
Aurora Mobile's GPTBots.ai Enhances Customer Service Solution with Audio Agent and LINE Plugin 2.0

Aurora Mobile's GPTBots.ai Enhances Customer Service Solution with Audio Agent and LINE Plugin 2.0

SINGAPORE, July 23, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, announced enhancements to the customer service solution on GPTBots.ai, its enterprise-grade AI agent platform. GPTBots.ai Audio Agent now supports SIP connectivity via Twilio for integration with enterprise telephony infrastructure. LINE Customer Service Plugin 2.0 updates the agent workspace and adds notification capabilities for service teams.

Jul 23, 2026 03:00 AM • globenewswire.com
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM

VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ – VALU ) announced today that its Board of Directors declared on July 17, 2026 a quarterly cash dividend of $0.35 per common share, payable on August 11, 2026, to stockholders of record on July 27, 2026. The Company has 9,383,573 shares of common stock outstanding as of July 17, 2026.

Jul 17, 2026 12:05 PM • globenewswire.com
Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel, allogeneic, “off the shelf”, cell therapies for serious medical conditions, today provided an update on COR1, the Company's allogeneic corneal endothelial cell (CEnC) transplant program, in preclinical development for the treatment of corneal endothelial disease. With COR1, Lineage is deploying its ophthalmology and cell manufacturing expert.

Jul 13, 2026 04:00 AM • businesswire.com
Lineage: Don't Mistake A Cyclical Slump For A Broken Business

Lineage: Don't Mistake A Cyclical Slump For A Broken Business

Lineage remains a Buy, offering a margin of safety and re-rating potential despite near-term macro and operational headwinds. Q1 saw AFFO per share decline 9.3% to $0.78, but guidance for Adj. EBITDA ($1.25–$1.3B) and AFFO per share ($2.75–$3.00) were maintained. LINE's cost reduction plan and automation investments target $110M annualized EBITDA improvement in 3–5 years, supporting long-term upside.

Jul 09, 2026 03:01 AM • seekingalpha.com
Grand Design RV Unveils the All-New Lineage Series E, Redefining Innovation in Motorized RV Travel

Grand Design RV Unveils the All-New Lineage Series E, Redefining Innovation in Motorized RV Travel

MIDDLEBURY, Ind., July 08, 2026 (GLOBE NEWSWIRE) -- Grand Design RV, the fast-growing innovator of travel trailers, 5th wheels and motorized RVs, today announced the launch of the all-new Lineage series E, expanding its award-winning motorized portfolio with a new Class C motorhome designed to deliver premium comfort, practical functionality and confidence on the road. Built on the dependable Ford® E-450 chassis, the Series E brings Grand Design's owner-focused approach to one of the most established and accessible segments of the motorized RV market.

Jul 08, 2026 05:59 AM • globenewswire.com
Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp

Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / July 7, 2026 / Linear Minerals Corp. (CSE:LINE)(OTCID:LINMF) (WKN:A40Y3E) ("Linear" or the "Company") is pleased to provide an update on its previously announced letter of intent (the "LOI") to acquire all of the issued and outstanding securities of Critical Prospecting Corp. initially announced in the Company's news release dated May 21, 2026. The Company confirms that it continues to work towards completing the proposed acquisition of certain mineral properties (the "Properties") from Critical Prospecting Corp. (the "Vendor").

Jul 07, 2026 05:25 PM • accessnewswire.com
Lineage to Report Second-Quarter 2026 Financial Results on August 5, 2026

Lineage to Report Second-Quarter 2026 Financial Results on August 5, 2026

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE), announced that it will report its financial results for the second quarter of 2026 on Wednesday, August 5, 2026, before market open. A conference call to discuss these results has been scheduled for 8:00 a.m. Eastern Time on Wednesday, August 5, 2026. A live webcast of the call will be available on the Lineage Investor Relations website at ir.onelineage.com. An audio replay of the conference call will be available for one week followin.

Jul 07, 2026 12:15 PM • businesswire.com
Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit

Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today announced that Brian M. Culley, Lineage's Chief Executive Officer, will be presenting at the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit, in a fireside chat hosted by Mayank Mamtani, Senior Managing Director, Group Head of Healthcare Research an.

Jul 06, 2026 04:00 AM • businesswire.com

Price Targets